Sean Kirk is VP at Emergent BioSolutions Inc. (EBS). They have made 1 open-market trade across 1 company since 2020, most recently 2021-03-31.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| EBS | 17,776 | $113K |
Shares reported on the most recent Form 4, priced at the 2021-04-01 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EBS | SELL | 2020-04-06 | 2020-04-08 | $60.00 | $966K | +5.5% | +27.2% | +41.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.